ENTITY
New Horizon Health

New Horizon Health (6606 HK)

60
Analysis
Health Care • China
New Horizon Health Limited operates cancer screening technology development business. The Company develops and sells colorectal cancer screening test products, gastric cancer screening test products, and other products. New Horizon Health markets its products throughout China.
more
bullish•New Horizon Health
•05 Feb 2021 13:45

New Horizon Health (诺辉偄康) IPO: Room to Fly

We think there is substantial upside from the high end. The line-up of cornerstone investors is strong. We are seeing strong demand from...

Logo
2k Views
Share
bullish•New Horizon Health
•04 Feb 2021 22:20

New Horizon Health IPO: Valuation Insights

New Horizon will raise gross proceeds of $244 million at the mid-point of the proposed IPO price range of HK$22.70-26.66. We would participate in...

Logo
1.1k Views
Share
bullish•New Horizon Health
•03 Feb 2021 02:43

New Horizon Health IPO: PHIP Updates

New Horizon Health operates in the Chinese colorectal cancer screening market. The company has filed for an IPO on the HKEX and plans to raise...

Share
bullish•New Horizon Health
•02 Feb 2021 23:06

New Horizon Health IPO: Poised for Growth

New Horizon is set to launch a $300m HK IPO on Thursday. The PHIP which disclose the 9M20 results and the all-important NMPA approval for ColoClear...

Logo
356 Views
Share
bullish•Kuaishou Technology
•24 Jan 2021 09:14

ECM Weekly (24 January 2021) - Kuaishou, New Horizon Health, Indigo Paints, Home First Fin, IRFC

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
x